Cointime

Vulcan Biologics

company

About

Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of microbiomes.

Highlights

Total Funding Amount
$0.98M
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.98M
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2019
Operating Status
Active

Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of the microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiome. Its platform uses bacteriophages that alter the gut bacterias of the microbiome that helps in the treatment of gluten-related disorders like gluten sensitivity and celiac disease.

Vulcan Biologics was founded in 2019 and is headquartered in Irvine, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$0.98M
Vulcan Biologics has raised a total of $0.98M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 8, 2021 Grant $0.98M 1 National Science Foundation — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Vulcan Biologics has made 1 investments. Their most recent investment was on May 1, 2013, when Mirakl Target2Sell raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
May 1, 2013 Mirakl Target2Sell
Seed — Artificial Intelligence —

Investors

Number of Lead Investors
Number of Investors
1
1
Vulcan Biologics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
Содержание
компания